Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Acta Endocrinol (Buchar) ; 17(2): 157-167, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34925563

RESUMO

BACKGROUND: Pomegranate is a rich source of many polyphenolic compounds including ellagitannins (punicalagin, punicalin and others). AIM: The effects of punicalagin and punicalin on adipogenesis were investigated in this study. MATERIALS AND METHODS: To examine the effect of punicalagin and punicalin on adipocyte differentiation, various concentrations of punicalagin and punicalin (2-10 µM) were applied to differentiated 3T3-L1 cells. Glyceraldehyde-3-phosphate dehydrogenase (GPDH) activity, Oil red O staining, intracellular triglyceride levels, and gene expressions of transcription factors (Peroxisome proliferator-activated receptor-γ (PPARγ), CCAAT-enhancer-binding proteins-α (C/EBPα), Sterol regulatory element-binding protein 1c (SREBP-1c)) and lipolysis-associated genes (hormone-sensitive lipase (HSL), Perilipin A, tumor necrosis factor-α (TNF-α)) were examined in order to investigate the effects of punicalagin and punicalin on adipocyte differentiation. RESULTS: Punicalagin and punicalin applications caused a continuous decrease in cell size and intracellular triglyceride accumulation. GPDH activity and transcription gene expressions decreased significantly in groups that were applicated punicalagin and punicalin at high concentrations. Punicalagin, but not punicalin, down-regulated the expression of HSL and perilipin A and up-regulated the expression of TNF-α in a dose-dependent manner. In conclusion, both punicalagin and punicalin were able to inhibit the adipocyte differentiation.

2.
Acta Endocrinol (Buchar) ; 15(2): 165-172, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31508172

RESUMO

CONTEXT: The inhibition of adipocyte differentiation has a significant role on the prevention of obesity and obesity-associated complications. OBJECTIVE: In this study, we aimed to detect whether hyperoside is able to inhibit the conversion of pre-adiposits into mature adiposits. DESIGN AND METHODS: 3T3-L1 pre-adipocytes were stimulated so as to differentiate into mature adipocytes. Hyperoside in non-cytotoxic concentrations (1, 2, 5, and 10 µM) were separately applied to differentiated 3T3-L1 cells. Oil red O staining was performed and triacylglycerol contents were measured. Furthermore, gene and protein expressions of transcription factors, adipogenic genes and adipokines were examined in order to investigate the effect of hyperoside on adipocyte differentiation. RESULTS: Hyperoside in high concentrations significantly suppressed the adipogenic process by inhibiting the expression of transcription factors and adipogenic genes and reducing lipid accumulation in adipocytes (p<0.05). Low doses of hyperoside are able to inhibit adipogenesis, but higher doses are needed to reduce fat accumulation in mature adipocytes. In the case of maturing preadipocytes, 5 µM of hyperoside exerts its antiadipogenic effect at the early stages of adipogenesis, whereas 10 µM of hyperoside acts at the later stages (p<0.05). CONCLUSION: These results suggest that hyperoside has a beneficial effect on the prevention and treatment of obesity.

3.
J Laryngol Otol ; 130(12): 1103-1109, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27707425

RESUMO

OBJECTIVES: This study aimed to explore the effects of curcumin on experimental allergic rhinitis in rats. METHODS: Twenty-eight male Wistar albino rats were randomly divided into four groups: a control group; a group in which allergic rhinitis was induced and no treatment given; a group in which allergic rhinitis was induced followed by treatment with azelastine hydrochloride on days 21-28; and a group in which allergic rhinitis was induced followed by treatment with curcumin on days 21-28. Allergy symptoms and histopathological features of the nasal mucosa were examined. RESULTS: The sneezing and nasal congestion scores were higher in the azelastine and curcumin treatment groups than in the control group. Histopathological examination showed focal goblet cell metaplasia on the epithelial surface in the azelastine group. In the curcumin group, there was a decrease in goblet cell metaplasia in the epithelium, decreased inflammatory cell infiltration and vascular proliferation in the lamina propria. CONCLUSION: Curcumin is an effective treatment for experimentally induced allergic rhinitis in rats.


Assuntos
Antialérgicos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Curcumina/farmacologia , Células Caliciformes/efeitos dos fármacos , Mucosa Nasal/efeitos dos fármacos , Ftalazinas/farmacologia , Rinite Alérgica/patologia , Espirro/efeitos dos fármacos , Administração Intranasal , Animais , Condrócitos/efeitos dos fármacos , Condrócitos/patologia , Cílios/efeitos dos fármacos , Cílios/patologia , Eosinófilos/efeitos dos fármacos , Células Caliciformes/patologia , Hiperemia , Hipertrofia , Masculino , Mastócitos/efeitos dos fármacos , Metaplasia , Mucosa Nasal/patologia , Ovalbumina/efeitos adversos , Distribuição Aleatória , Ratos , Ratos Wistar
4.
Eur Rev Med Pharmacol Sci ; 18(4): 477-84, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24610613

RESUMO

The naphthylamine derivative sertraline is a potent and selective inhibitor of serotonin reuptake into presynaptic terminals and the most widely used that has been shown to have both antidepressant and antianxiety effects. In the present study the possible role of sertraline (acute and chronically doses) was evaluated on lipid peroxidation levels and antioxidant enzyme activities in plasma and brain tissues of (10, 40, 80 mg/kg) sertraline treated Wistar albino rats (n=48). Lipid peroxidation levels (MDA) of plasma and brain tissue increased in all acute and chronic sertraline treated rats (p < 0.05). According to results of present study superoxide dismutase (SOD) levels of brain tissue decreased while plasma levels increased (p < 0.05) as compared with vehicle group. Catalase (CAT) levels of plasma and brain tissue and paraoxonase (PON) levels of plasma decreased (p < 0.05) as compared with vehicle group. Based on the data, it can be concluded that high dose sertraline administration enhances oxidative stress. Therefore, dose adjustment in depression patients seems significant as it may help prevention of further prognosis of the diseases.


Assuntos
Encéfalo/efeitos dos fármacos , Oxidantes/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Inibidores Seletivos de Recaptação de Serotonina/toxicidade , Sertralina/toxicidade , Animais , Arildialquilfosfatase/sangue , Biomarcadores/sangue , Encéfalo/metabolismo , Catalase/sangue , Relação Dose-Resposta a Droga , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Malondialdeído/sangue , Ratos Wistar , Superóxido Dismutase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA